Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $90.69 USD
Change Today +0.67 / 0.74%
Volume 319.4K
AGIO On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David P. Schenkein M.D.

Chief Executive Officer, President and Director,Agios Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 49 board members in 5 different organizations across 8 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. David P. Schenkein, M.D. has been the Chief Executive Officer at Agios Pharmaceuticals, Inc. since August 2009 and serves as its President. Dr. Schenkein served as a Senior Vice President of Clinical Hematology & Oncology at Genentech, Inc. Additionally, Dr. Schenkein is an Associate Professor of Medicine at Tufts University School of Medicine. He serves as an adjunct Clinical Professor of Medicine at the Stanford University Cancer Center. He has been a Medical Oncologist ...

Read Full Background

Corporate Headquarters*

38 Sidney Street
Cambridge, Massachusetts 02139

United States

Phone: 617-649-8600
Fax: --

Board Members Memberships*

Chief Executive Officer, President and Director
Director and Member of Audit Committee
Director and Chairperson of Nominating & Corporate Governance Committee


Wesleyan University
SUNY Upstate Medical University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$500,000

Stock Options*

All Other Compensation$1,978
Exercised Options118,000
Exercised Options Value$5,590,265
Exercisable Options595,594
Exercisable Options Value$66,429,898
Unexercisable Options182,726
Unexercisable Options Value$15,365,541
Total Value of Options$101,429,730
Total Number of Options1,032,683

Total Compensation*

Total Annual Cash Compensation$873,228
Total Short Term Compensation$500,000
Other Long Term Compensation$1,978
Total Calculated Compensation$4,359,241
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGIO:US $90.69 USD +0.67


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AGIOS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at